The limitations of antipsychotic medication on schizophrenia relapse and adjustment and the contributions of psychosocial treatment

Journal of Psychiatric Research

Volumn 32, Issue 3-4, 1998, Pages 243-250

  Hogarty, Gerard E ^a   Ulrich, Richard F ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

DRUG EFFICACY; HUMAN; MAINTENANCE THERAPY; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RECURRENCE RISK; RELAPSE; REVIEW; RISK; SCHIZOPHRENIA; SOCIAL ADAPTATION; SOCIAL SUPPORT; STRESS;

EID: 0032071193     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(97)00013-7     Document Type: Article

References (44)

1. Anderson, C., Hogarty, G., and Reiss, D. (1980). Family treatment of adult schizophrenic patients: A psychoeducational approach. Schizophrenia Bulletin, 6, 495-505.
2. Baldessarini, R., & Viguera, A. (1995). Neuroleptic withdrawal in schizophrenic patients. Archives of General Psychiatry, 52, 189-192.
3. Bellack, A., & Mueser, K. (1993). Psychosocial treatment for schizophrenia. Schizophrenia Bulletin, 19, 317-336.
4. Caffey, E., Diamond, L., Frank, T., Grasberger, J., Herman, L., Klett, J., & Rothstein, C. (1964). Discontinuation or reduction of chemotherapy in chronic schizophrenics. Journal of Chronic Disease, 17, 347-350.
5. Crow, T., MacMillan, J., Johnson, A., & Johnstone, E. (1986). The Northwick Park study of first episodes of schizophrenia. II. A randomized controlled trial of prophylactic neuroleptic treatment. British Journal of Psychiatry, 148, 120-127.
6. Dixon, L., & Lehman, A. (1995). Family interventions for schizophrenia. Schizophrenia Bulletin, 21, 631-643.
7. Falloon, I., Boyd, J., McGill, C., Williamson, W., Razoni, J., Moss, H., Gilderman, A., & Simpson, G. (1985). Family management in the prevention of morbidity of schizophrenia. Archives of General Psychiatry, 42, 887-896.
8. Gilbert, P., Harris, M., McAdams, L., & Jeste, D. (1995). Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Archives of General Psychiatry, 52, 173-188.
9. Goldberg, S., Schooler, N., Hogarty, G., & Roper, M. (1977). Prediction of relapse in schizophrenic outpatients treated by drug and sociotherapy. Archives of General Psychiatry, 34, 171-184.
10. Hogarty, G. (1984). Depot neuroleptics: the relevance of psychosocial factors. Journal of Clinical Psychiatry, 45(Suppl.), 36-42.
11. Hogarty, G., Anderson, C., Reiss, D., Kornblith, S., Greenwald, D. P., Javna, C. D., Madonia, M., & EPICS Research Group, A. (1986) Family psychoeducation, social skills training and maintenance chemotherapy in the aftercare treatment of schizophrenia. I. One-year effects of a controlled study on relapse and expressed emotion. Archives of General Psychiatry, 43, 633-642.
12. Hogarty, G., Anderson, C., Reiss, D., Kornblith, S., Greenwald, D., Ulrich, R., Carter, M., & EPICS Research Group, A. (1991) Family psychoeducation, social skills training, and maintenance chemotherapy in the aftercare of treatment of schizophrenia. II. Two-year effects of a controlled study on relapse and adjustment. Archives of General Psychiatry, 48, 340-347
13. Hogarty, G. & Flesher, S. (pre-publication report). A developmental approach to the cognitive rehabilitation of schizophrenic patients: Theory and practice of Cognitive Enhancement Therapy.
14. Hogarty, G., Goldberg, S., & Collaborative Study Group, A. (1973). Drug and sociotherapy in the aftercare of schizophrenic patients: One year relapse rates. Archives of General Psychiatry, 28, 54-64.
15. Hogarty, G., Goldberg, S., Schooler, N., Ulrich, R., & Collaborative Study Group, A. (1974). Drug and sociotherapy in the aftercare of schizophrenic patients. II: Two-year relapse rates. Archives of General Psychiatry, 31, 603-608.
16. Hogarty, G., Goldberg, S., Schooler, N., & Collaborative Study Group, A. (1974). Drug and sociotherapy in the aftercare of schizophrenic patients. III: Adjustment of nonrelapsed patients. Archives of General Psychiatry, 31, 609-618.
17. Hogarty, G., Kornblith, S., Greenwald, D., DiBarry, A., Cooley, S., Flesher, S., Reiss, D., Carter, M., & Ulrich, R. (1995). Personal therapy: A disorder-relevant psychotherapy for schizophrenia. Schizophrenia Bulletin, 21, 379-393.
18. Hogarty, G., Greenwald, D., Ulrich, R., Kornblith, S., DiBarry, A., Cooley, S., Carter, M., & Flesher, S. (1997a). Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients. American Journal of Psychiatry, 154, 1514-1524.
19. Hogarty, G., Kornblith, S., Greenwald, D., DiBarry, A., Cooley, S., Ulrich, R., Carter, M., & Flesher, S. (1997b). Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates. American Journal of Psychiatry, 154, 1504-1513.
20. Hogarty, G., McEvoy, J., Munetz, M., DiBarry, A., Bartone, P., Cather, R., Cooley, S., Ulrich, R., Carter, M., Madonia, M., & EPICS Research Group (1988). Dose of fluphenazine, familial expressed emotion, and outcome in schizophrenia. Archives of General Psychiatry, 45, 797-805.
21. Hogarty, G., Schooler, N., Ulrich, R., Mussare, F., Herron, E., & Ferro, P. (1979) Fluphenazine and social therapy in the aftercare of schizophrenic patients: Relapse analysis of a two-year controlled study of fluphenazine decanoate and fluphenazine hydrochloride. Archives of General Psychiatry, 36, 1283-1294.
22. Hogarty, G., Ulrich, R., Mussare, F., & Aristiqueta, N. (1976). Drug discontinuation among long-term successfully maintained schizophrenic outpatients. Diseases of the Nervous System, 37, 494-500.
23. Hogarty, G., & Ulrich, R. (1977). Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. Archives of General Psychiatry, 34, 297-301.
24. Jeste, D., Gilbert, P., McAdams, L., & Harris, M. (1995). Considering neuroleptic maintenance and taper on a continuum. Archives of General Psychiatry, 52, 210.
25. Johnson, D., Ludlow, J., Street, K., & Taylor, R. (1987). Double-blind comparison of half dose and standard dose flupenthixol decanoate in the maintenance treatment of stabilized outpatients with schizophrenia. British Journal of Psychiatry, 151, 634-638.
26. Johnson, D., Pasterski, G., Ladlow, J., Street, K., & Taylor, R. (1983). The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients. Acta Psychiatrica Scandinavia, 67, 339-352.
27. Judah, L., Joseph, Z., & Murphree, O. (1961). Results of simultaneous abrupt withdrawal of ataraxics in 500 chronic psychotic patients. American Journal of Psychiatry, 118, 156-158.
28. Kane, J., Rifkin, A., Quitkin, F., Nayah, D., & Ramos-Lorenzi, J. (1982). Fluphenazine vs placebo in patients with remitted, acute first-episode schizophrenia. Archives of General Psychiatry, 39, 70-73.
29. Kane, J., Woerner, M., & Sarantakos, S. (1986). Depot neuroleptics: A comparative review of standard, intermediate and low dose regimens. Journal of Clinical Psychiatry, 47(Suppl.), 30-33.
30. Kavanagh, D. (1992). Recent developments in expressed emotion and schizophrenia. British Journal of Psychiatry, 160, 601-620.
31. Leff, J., Kuipers, L., Berkowitz, R., & Sturgeon, D. (1985). A controlled trial of social intervention in the families of schizophrenic patients: Two-year follow-up. British Journal of Psychiatry, 146, 594-600.
32. Lehman, A. (1995). Vocational rehabilitation in schizophrenia. Schizophrenia Bulletin, 21, 645-656.
33. Lehman, A., Carpenter, W., Goldman, H., & Steinwachs, D. (1995). Treatment outcomes in schizophrenia: Implications for practice, policy and research. Schizophrenia Bulletin, 21, 669-674.
34. Liberman, R., VanPutten, T., Barringer, M., Mintz, J., Bowen, L., Kuehnel, T., Aravagiri, M., & Marder, S. (1994). Optimal drug and behavior therapy for treatment-refractory schizophrenic patients. American Journal of Psychiatry, 151, 756-757.
35. Marder, S., VanPutten, T., Muntz, J., Lebell, M., McKenzie, J., & May, P. (1987). Low and conventional dose maintenance therapy with fluphenazine decanoate. Archives of General Psychiatry, 44, 518-521.
36. McEvoy, J., Hogarty, G., & Steingard, S. (1991). Optimal dose of neuroleptic in acute schizophrenia. Archives of General Psychiatry, 48, 739-745.
37. Meltzer, H., Thompson, P., Lee, M., & Ranjan, R. (1996). Neuropsychologic deficits in schizophrenia: Relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology, 14(Suppl.), 27-33.
38. Prien, R., Cole, J., & Belkin, F. (1968). Relapse in chronic schizophrenics following abrupt withdrawal of tranquilizing medication. British Journal of Psychiatry, 115, 679-686.
39. Prien, R., Levine, J., & Cole, J. (1969). High dose trifluopenzine therapy in chronic schizophrenia. American Journal of Psychiatry, 126, 305-313.
40. Schooler, N., & Keith, S. (1993). The clinical research base for the treatment of schizophrenia. Psychopharmacology Bulletin, 29, 431-446.
41. Schooler, N., Levine, J., Severe, J., Brauzer, B., DiMascio, A., Klerman, G., & Tuason, V. (1980). Prevention of relapse in schizophrenia: An evaluation of fluphenazine decanoate. Archives of General Psychiatry, 37, 16-24.
42. Scott, J., & Dixon, L. (1995). Assertive community treatment and case management for schizophrenia. Schizophrenic Bulletin, 21, 657-668.
43. Scott, J., & Dixon, L. (1995). Psychological interventions for schizophrenia. Schizophrenia Bulletin, 21, 621-630.
44. Smith, R. (1994). Lower dose therapy with traditional neuroleptics in chronically hospitalized schizophrenic patients. Archives of General Psychiatry, 51, 427-429.